BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8356244)

  • 21. [Prostatic adenocarcinoma. I. History of its treatment and study of its prognostic factors. Review of the literature].
    Valls Fontanals A; Panadés Nigorra G; Ballester Moll T
    Actas Urol Esp; 1985; 9(2):109-14. PubMed ID: 3893052
    [No Abstract]   [Full Text] [Related]  

  • 22. A re-assessment of the role of combined androgen blockade for advanced prostate cancer.
    Klotz L; Schellhammer P; Carroll K
    BJU Int; 2004 Jun; 93(9):1177-82. PubMed ID: 15180600
    [No Abstract]   [Full Text] [Related]  

  • 23. [The immune homeostasis of patients with prostatic cancer on hormonal chemotherapy, radiation treatment and immunological action].
    Panteleeva ES; Sviridova TV; Neprina GS; Sirotkina NP
    Urol Nefrol (Mosk); 1996; (1):28-31. PubMed ID: 8659039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New potential treatment modalities for disseminated prostatic cancer.
    Creaven PJ; Madajewicz S; Mittelman A
    Urol Clin North Am; 1984 May; 11(2):343-56. PubMed ID: 6203208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous endocrine management and chemotherapy as initial treatment in M1 prostatic carcinoma.
    Richards B
    Prog Clin Biol Res; 1988; 269():177-86. PubMed ID: 2839846
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of hormone refractory prostate cancer.
    Panvichian R; Pienta KJ
    Compr Ther; 1996 Feb; 22(2):81-7. PubMed ID: 8689867
    [No Abstract]   [Full Text] [Related]  

  • 27. [The contribution of hormone therapy (single or combined) to the prognosis of solid tumors].
    Longueville J
    Rev Med Liege; 1984 Feb; 39(3):108-10. PubMed ID: 6718862
    [No Abstract]   [Full Text] [Related]  

  • 28. [Radiochemotherapy and simultaneous hormonal therapy of locally advanced prostatic carcinoma].
    Strnad V; Riepl M; Kühn R; Sauer R
    Strahlenther Onkol; 1996 Apr; 172(4):225-8. PubMed ID: 8623086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary squamous cell carcinoma of the prostate: a novel chemotherapy regimen.
    Majeed F; Javed TA; Khan AU; Koerber RK
    J Urol; 2002 Aug; 168(2):640. PubMed ID: 12131330
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy of advanced prostatic carcinoma.
    Millikan RE
    Semin Oncol; 1999 Apr; 26(2):185-91. PubMed ID: 10597729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseases.
    Evans CP; Fleshner N; Fitzpatrick JM; Zlotta AR
    BJU Int; 2005 Apr; 95(6):743-9. PubMed ID: 15794775
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chemotherapy in prostatic carcinoma].
    Pérez Manga G; Arranz Arija JA; García Gómez R; Salinas Hernández P; González del Val R
    Arch Esp Urol; 1993 Mar; 46(2):116-26. PubMed ID: 8498851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma--new developments in diagnosis and therapy.
    Schneeberger A; Wagner SN
    Cancer Chemother Biol Response Modif; 2003; 21():609-36. PubMed ID: 15338766
    [No Abstract]   [Full Text] [Related]  

  • 34. Carcinoma of the prostate: a review. II. Treatment according to clinical stage of the cancer.
    Blackard CE
    J Lancet; 1968 Jan; 88(1):5-15. PubMed ID: 4865761
    [No Abstract]   [Full Text] [Related]  

  • 35. Genitourinary malignancies.
    Smith MR; Kantoff P
    Cancer Chemother Biol Response Modif; 1999; 18():394-417. PubMed ID: 10800495
    [No Abstract]   [Full Text] [Related]  

  • 36. Other chemotherapy regimens including mitoxantrone and suramin.
    Siu LL; Moore MJ
    Semin Urol Oncol; 1997 Feb; 15(1):20-7. PubMed ID: 9050136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer--treatment of disseminated disease.
    Abi-Aad AS; Opsomer RJ
    Acta Urol Belg; 1996 May; 64(2):67-76. PubMed ID: 8701817
    [No Abstract]   [Full Text] [Related]  

  • 38. [Update on the medical treatment of urologic tumors].
    Culine S
    Bull Cancer; 2000 Jan; 87(1):71-5. PubMed ID: 10673634
    [No Abstract]   [Full Text] [Related]  

  • 39. [Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate].
    Matveev BP; Bukharkin BV
    Vopr Onkol; 1998; 44(5):537-40. PubMed ID: 9884710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy for prostatic carcinoma.
    Eisenberger MA; Abrams JS
    Semin Urol; 1988 Nov; 6(4):303-10. PubMed ID: 3068768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.